Barry Davison, Ph.D., provides patent preparation and prosecution services, in domestic and foreign patents, primarily for clients in the biotechnology, biomedical, software, and life sciences industries, and including patent related licensing, due diligence, portfolio management, and legal opinions.
He focuses particularly on patent drafting, procurement management in biotechnology in the areas of molecular biology, nucleic acids, small molecule (pharmaceuticals), DNA, genomics and epigenomics, transgenics, immunology, biochemistry, bioassays, chemistry, materials science, and medical devices.
Past Director, Molecular Immunology/Transgenics Department, Immunex Corporation
Prior Consultant, biotech and biomed patent prosecution and strategic analysis
Clerk, Washington State Office of the Attorney General
Professional & Community Activities:
Washington State Patent Law Association
American Bar Association
American Intellectual Property Association
American Chemical Society
Predoctoral Fellow, Jan Coffin Childs Memorial Fund for Medical Research, Strasbourg, France
Senior Postdoctoral Fellow, National Institutes of Health
J.D., University of Washington School of Law, 1999
Ph.D., Biochemistry, Molecular Biology, University of California, Berkeley